Nestle raises stake in food allergy drug developer Aimmune Medical Dialogues Bureau13 Nov 2018 3:53 PM ISTThe health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics Inc, the drug developer said, as it prepares to...
Aclaris's drug to treat common skin growth gets FDA nod Ruby Khatun Khatun18 Dec 2017 10:00 AM ISTAclaris Therapeutics Inc's drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug...
Roche drug cocktail doubles chance of holding lung cancer at bay Ruby Khatun Khatun9 Dec 2017 9:45 AM ISTZURICH: Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease...
FDA approves Novo Nordisk diabetes drug Ozempic Ruby Khatun Khatun6 Dec 2017 10:30 AM ISTThe U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli...
Ajanta Pharma launches generic ADHD treatment drug in US Ruby Khatun Khatun23 Nov 2017 10:15 AM ISTNew Delhi: Drug firm Ajanta Pharma said it has launched generic Clonidine Hydrochloride extended-release tablets in the American market after...
Johnson multiple myeloma drug succeeds in first-line combination study Ruby Khatun Khatun23 Nov 2017 10:00 AM ISTJohnson and Johnson's blockbuster multiple myeloma drug Darzalex when added to a standard therapy regimen reduced the risk of disease progression or...
FDA approves first drug in US with digital ingestion tracking Ruby Khatun Khatun15 Nov 2017 10:45 AM ISTThe U.S. Food and Drug Administration (FDA) approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole...
FDA OKs Merck drug that prevents infection post-stem cell transplant Ruby Khatun Khatun11 Nov 2017 10:01 AM ISTMerck & Co Ltd's drug to prevent serious infection in patients who undergo a type of stem cell transplant was approved by the U.S. Food and Drug...
Mallinckrodt dives as sales of main drug Acthar disappoint Ruby Khatun Khatun9 Nov 2017 9:37 AM ISTShares of Mallinckrodt Plc plunged more than 30 percent to an all-time low on Tuesday after the drugmaker reported disappointing quarterly revenue and...
FDA approves intravenous version of Tesaro drug for chemotherapy nausea Ruby Khatun Khatun28 Oct 2017 9:44 AM ISTTesaro Inc said on Wednesday that the U.S. Food and Drug Administration (FDA) approved an intravenous version of its drug to treat...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Lupin to add GLP 1 analog to its diabetes portfolio in India Ruby Khatun Khatun13 Sept 2017 3:07 PM ISTMumbai: Lupin plans to introduce a new class of diabetes drugs in India through in-licensing agreements in order to enhance its diabetes drugs...
